BD² recently announced a fourth round of funding opportunities, inviting teams to apply for up to $4.5 million per grant to undertake groundbreaking research into the genetic, molecular, cellular, ...

Today, BD², or Breakthrough Discoveries for thriving with Bipolar Disorder, announced its third round of Discovery Research ...

Uzedy administered once every 2 months is not recommended for the maintenance treatment of bipolar I disorder. The Food and Drug Administration (FDA) has approved Uzedy ® (risperidone extended-release ...

The Icahn School of Medicine at Mount Sinai is pleased to announce it has received a three-year, $4.5 million grant from BD2: ...

Teva Pharmaceuticals and Medincell recently announced that the FDA has approved UZEDY® (risperidone), a once-monthly ...

Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers ...

Teva Pharmaceuticals and Medincell have gained approval from the US Food and Drug Administration (FDA) for Uzedy (risperidone), a once-a-month extended-release injectable suspension to treat adult ...

Bipolar disorder treatment often includes some combination of medications like mood stabilizers and antidepressants alongside therapy.

Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. Bristol-Myers Squibb Company (BMY) ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best high volume stocks to buy according to Wall Street ...

The rapper’s new book, Episodes: The Diary of a Recovering Mad Man, was released on October 14. According to People, Gucci Mane reveals that he’s been living with schizophrenia and bipolar disorder.